In 2006, Genzyme’s global CEO, Henri Termeer, said he is “personally very interested in China” and that he expects the company to build a capable infrastructure…
In Conversation
Maver has an impressive track record in developing and commercializing blockbuster products for the Chilean market, such as Tapsin and Disfruta, which today are the #1…
What have been Boehringer Ingelheim’s major milestones and achievements since your establishment in Chile? Chile, in the regional context, represents a very important market with a…
What was the transition like from academia into entrepreneurship and what challenges did you face in beginning this company? I realized during this period in the…
The Bayer Schering merger in 2006 saw you add Argentina and Bolivia to your existing main milestones and achievements of the company since you have been…
As growth has stalled in Europe, the US and Japan, many multinational companies are looking at China as part of a hedging strategy and a key…
"There is an ageing population [in China] with an epidemiological profile that is increasingly aligned with that of the West. These are elements that favor global…
Could you please give a brief introduction to the ABO and its history? ABO was established in 2005. The CRO business emerged in 2000 in China,…
You have been here in China for about a year. What were your assumptions about China before you arrived and were things more or less what…
First, let me briefly introduce myself. I used to work in Fuxin, a small city in the industrially advanced province of Liaoning which is equivalent to…
You have an MD and you’ve worked in industry, but then you decided to become and entrepreneur. What challenges did you face in transitioning to starting…
You started the Chinese operations and have been working in the country for many years but recently moved up to running all operations in Asia Pacific.…
